240

ZTZ240 is a KCNQ2 channel activator used in the study of epilepsy.

ERG240 is an inhibitor of branched-chain amino acid aminotransferase 1 (BCAT1). ERG240 can be used for the research of rheumatoid arthritis, cancer, and bone disease.

ML240 is a selective, ATP-competitive p97 inhibitor.

Elastase from porcine pancreas is a serine protease derived from the porcine pancreas, consisting of 240 amino acid residues. It has the ability to hydrolyze proteins and peptides, can induce emphysema in hamsters, and is commonly used to establish animal models of chronic obstructive pulmonary disease (COPD).

Upacicalcet (AJT-240) is an intraventricular calcium mimetic, a SHPT available for human hemodialysis, that inhibits excessive parathyroid hormone (PTH) secretion by directly acting on parathyroid cell membrane calcium-sensitive receptors, thereby lowering blood levels of PTH.Upacicalcet is an orthosteric modulator of calcium-sensitive receptors and prevents adenine-induced secondary vascular calcification and bone disease in a rat model of adenine-induced secondary hyperparathyroidism.

C.I. Food Blue 1-aluminum lake is a type of colorant.

EU 1622-240 is an allosteric modulator with a preference for GluN2B, GluN2C, and GluN2D, exhibiting EC50 values of 0.57, 0.82, and 1.1 μM, respectively. It possesses favorable physicochemical properties, along with in vitro stability and permeability.

Anticanceragent 240 (compound 9b) is an 8-quinolinesulfonamide derivative with cytotoxic activity. It exhibits inhibitory effects on the Caco-2, SNB-19, A-549, and SKOV-3 cell lines, with IC50 values of 0.26, 0.38, 0.40, and 4.16 μM, respectively.

sCNH240 (2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamide) is a potential and selective Rv1625c/Cya activator with good cell permeability and oral activity, IC90=1.24 μM in cholesterol-supplemented 7H12 medium against Mycobacterium tuberculosis (Mtb) H37Rv strain, and inhibition of CYP2C19, CYP2C9 and hERG channels.

Anti bacterial agent 240 (compound 62-7c) is an antimicrobial agent targeting multiple drug-resistant (MDR) MRSA strains. It demonstrates high biosafety and potent efficacy against infections in murine models of MRSA pneumonia and wound infections.

Anti-RHD/CD240d Antibody is a human-derived antibody expressed in CHO cells, targeting RHD/CD240d. It features a huIgG1 heavy chain and a huκ light chain, with an anticipated molecular weight (MW) of 146.4 kDa. For its isotype control, please refer to HumanIgG1kappa, Isotype Control.

p53 (232-240), a peptide derived from the 232-240 amino acid sequence of the human tumor suppressor protein p53, improves its binding affinity to the Major Histocompatibility Complex (MHC). This enhancement increases the immunogenicity of the peptide, boosting the immune system's response to tumor antigens. p53 (232-240) is valuable in the development of cancer vaccines and aids in researching how the immune system recognizes and eliminates tumor cells.

UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.

L-161240 is an antimicrobial agent associated with lipid A biosynthesis with an IC50 value of 30 nM as determined by DEACET and a MIC value of 1-3 μg/ mL against wild-type E. coli.

ZINC12409120 (R-4584) is a selective ERK inhibitor.ZINC12409120 inhibits ERK with an IC50 of 5.0 μM.ZINC12409120 inhibits ERK activity by interfering with FGF23:α-Klotho interaction.

Compound FL0240, with CAS No. 889944-57-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0240 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12400, with CAS No. 230-07-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12400 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14240, with CAS No. 146533-47-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14240 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

KSD 2405 (3-Hydroxybenzyl alcohol) is a hydroxybenzyl alcohol that is phenol substituted at position C-3 by a hydroxymethyl group. It is a pink or beige to brown crystalline powder, soluble in water.

Compound Fr12401, with CAS No. 230-46-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12401 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12403, with CAS No. 5766-40-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12403 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12404, with CAS No. 18927-05-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12404 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12405, with CAS No. 62356-51-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12405 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12406, with CAS No. 499770-81-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12406 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.